Kết quả tìm kiếm - Jan Moritz Middeke

Tinh chỉnh kết quả
  1. 1
    Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase

    Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase Bằng Nael Alakel, Jan Moritz Middeke, Johannes Schetelig, Martin Bornhäuser

    Được phát hành 2017
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects

    Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects Bằng Jan‐Niklas Eckardt, Martin Bornhäuser, Karsten Wendt, Jan Moritz Middeke

    Được phát hành 2020
    lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP

    Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP Bằng Julia-Annabell Georgi, Jan Moritz Middeke, Martin Bornhäuser, Axel Matzdorff, Karolin Trautmann‐Grill

    Được phát hành 2023
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    MRI-Based Liver Iron Content Predicts for Nonrelapse Mortality in MDS and AML Patients Undergoing Allogeneic Stem Cell Transplantation

    MRI-Based Liver Iron Content Predicts for Nonrelapse Mortality in MDS and AML Patients Undergoing Allogeneic Stem Cell Transplantation Bằng Martin Wermke, Anne Schmidt, Jan Moritz Middeke, Katja Sockel, Malte von Bonin, Claudia Schönefeldt, Sabine Mair, Verena Plodeck, Michael Laniado, Günter Weiß, Johannes Schetelig, Gerhard Ehninger, Igor Theurl, Martin Bornhäuser, Uwe Platzbecker

    Được phát hành 2012
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML

    Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML Bằng Martin Wermke, Sabrina Kraus, Armin Ehninger, Ralf C. Bargou, Maria-Elisabeth Goebeler, Jan Moritz Middeke, Carla Kreissig, Malte von Bonin, Jan Koedam, Michael Pehl, Martin Bornhäuser, Hermann Einsele, Gerhard Ehninger, Marc Cartellieri

    Được phát hành 2021
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  6. 6
    Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q−

    Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q− Bằng Jan Moritz Middeke, Dietrich W. Beelen, Michael Stadler, Gudrun Göhring, Brigitte Schlegelberger, H. Baurmann, Gesine Bug, Frauke Bellos, Brigitte Mohr, Stefanie Buchholz, Rainer Schwerdtfeger, Hans Martin, Ute Hegenbart, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig

    Được phát hành 2012
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  7. 7
    Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features

    Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features Bằng Leo Rasche, Christoph Röllig, Gernot Stuhler, Sophia Danhof, Stephan Mielke, Goetz Ulrich Grigoleit, Lea Dissen, Lea Schemmel, Jan Moritz Middeke, Viktoria Rücker, Martin Schreder, Johannes Schetelig, Martin Bornhäuser, Hermann Einsele, Christian Thiede, Stefan Knop

    Được phát hành 2016
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  8. 8
    Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment

    Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment Bằng Raphael Teipel, Frank Kroschinsky, Michael Krämer, Theresa Kretschmann, Katharina Egger‐Heidrich, Thomas Krüger, Leo Ruhnke, Sylvia Herold, Sebastian Stasik, Katja Sockel, Jan Moritz Middeke, Karolin Trautmann‐Grill, Martin Bornhäuser, Christian Thiede, Malte von Bonin

    Được phát hành 2022
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  9. 9
    Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease

    Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease Bằng Robert Zeiser, Nicola Polverelli, Ron Ram, Shahrukh K. Hashmi, Ronjon Chakraverty, Jan Moritz Middeke, Maurizio Musso, Sebastian Giebel, Ant Uzay, Peter Langmuir, Norbert Hollaender, Maanasa Gowda, Tommaso Stefanelli, Stephanie J. Lee, Takanori Teshima, Franco Locatelli

    Được phát hành 2021
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  10. 10
    The prevalence of extramedullary acute myeloid leukemia detected by <sup>18</sup>FDG-PET/CT: final results from the prospective PETAML trial

    The prevalence of extramedullary acute myeloid leukemia detected by <sup>18</sup>FDG-PET/CT: final results from the prospective PETAML trial Bằng Friedrich Stölzel, Tors Lüer, Steffen Löck, Stefani Parmentier, Friederike Kuithan, Michael Krämer, Nael Alakel, Katja Sockel, Franziska Taube, Jan Moritz Middeke, Johannes Schetelig, Christoph Röllig, Tobias Paulus, Jörg Kotzerke, Gerhard Ehninger, Martin Bornhäuser, Markus Schaich, Klaus Zoephel

    Được phát hành 2019
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  11. 11
    Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears

    Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears Bằng Jan‐Niklas Eckardt, Tim Schmittmann, Sebastian Riechert, Michael Krämer, Anas Shekh Sulaiman, Katja Sockel, Frank Kroschinsky, Johannes Schetelig, Lisa Wagenführ, Ulrich S. Schuler, Uwe Platzbecker, Christian Thiede, Friedrich Stölzel, Christoph Röllig, Martin Bornhäuser, Karsten Wendt, Jan Moritz Middeke

    Được phát hành 2022
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  12. 12
    Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

    Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation Bằng Jan Moritz Middeke, Min Fang, Jan J. Cornelissen, Brigitte Mohr, Frederick R. Appelbaum, Michael Stadler, Jaime Sanz, H. Baurmann, Gesine Bug, Kerstin Schäfer‐Eckart, Ute Hegenbart, Tilmann Bochtler, Christoph Röllig, Friedrich Stölzel, Roland B. Walter, Gerhard Ehninger, Martin Bornhäuser, Bob Löwenberg, Johannes Schetelig

    Được phát hành 2014
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  13. 13
    Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents

    Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents Bằng Anne Sophie Kubasch, Freya Schulze, Aristoteles Giagounidis, Katharina S. Götze, Jan Krönke, Katja Sockel, Jan Moritz Middeke, Fatiha Chermat, Silke Gloaguen, Martin Puttrich, Carmen Weigt, Doreen William, Pierre Fenaux, Richard F. Schlenk, Christian Thiede, Sebastian Stasik, Anna Mies, Lionel Adès, Uta Oelschlägel, Uwe Platzbecker

    Được phát hành 2019
    lấy văn bản lấy văn bản
    Carta
    Lưu vào danh sách
    Đã lưu trong:
  14. 14
    Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence

    Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence Bằng Jan‐Niklas Eckardt, Waldemar Hahn, Christoph Röllig, Sebastian Stasik, Uwe Platzbecker, Carsten Müller‐Tidow, Hubert Serve, Claudia D. Baldus, Christoph Schliemann, Kerstin Schäfer‐Eckart, Maher Hanoun, Martin Kaufmann, Andreas Burchert, Christian Thiede, Johannes Schetelig, Martin Sedlmayr, Martin Bornhäuser, Markus Wolfien, Jan Moritz Middeke

    Được phát hành 2024
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  15. 15
    The <scp><i>IKZF1</i> N159S</scp> mutation is associated with poor outcome and a distinct molecular profile in adult patients with <scp>AML</scp>

    The <scp><i>IKZF1</i> N159S</scp> mutation is associated with poor outcome and a distinct molecular profile in adult patients with <scp>AML</scp> Bằng Sebastian Stasik, Jan‐Niklas Eckardt, Christoph Röllig, Claudia D. Baldus, Uwe Platzbecker, Hubert Serve, Carsten Müller‐Tidow, Kerstin Schäfer‐Eckart, Martin Kaufmann, Stefan W. Krause, Tim Sauer, Mathias Hänel, Andreas Neubauer, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Jan Moritz Middeke, Christian Thiede

    Được phát hành 2025
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  16. 16
    Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia

    Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia Bằng Ridhima Lal, K. Lind, Ellen Heitzer, Peter Ulz, Kristina Aubell, Karl Kashofer, Jan Moritz Middeke, Christian Thiede, Eduard Schulz, Angelika Rosenberger, Sybille Hofer, Birgit Feilhauer, Beate Rinner, Vendula Švendová, Michael G. Schimek, Frank G. Rücker, Gerald Höefler, Konstanze Döhner, Armin Zebisch, Albert Wölfler, Heinz Sill

    Được phát hành 2017
    lấy văn bản lấy văn bản
    Carta
    Lưu vào danh sách
    Đã lưu trong:
  17. 17
    Gemtuzumab ozogamicin plus midostaurin in combination with standard ‘7 + 3’ induction therapy in newly diagnosed <scp>AML</scp>: Results from the <scp>SAL‐MODULE phase I</scp> study

    Gemtuzumab ozogamicin plus midostaurin in combination with standard ‘7 + 3’ induction therapy in newly diagnosed <scp>AML</scp>: Results from the <scp>SAL‐MODULE phase I</scp> stud... Bằng Christoph Röllig, Christoph Schliemann, Leo Ruhnke, Lars Fransecky, Björn‐Niklas Heydrich, Maher Hanoun, Richard Noppeney, Kerstin Schäfer‐Eckart, Knut Wendelin, Jan‐Henrik Mikesch, Jan Moritz Middeke, Manja Reimann, Frank Fiebig, Sven Zukunft, Martin Wermke, Hubert Serve, Uwe Platzbecker, Carsten Müller‐Tidow, Claudia D. Baldus, Martin Bornhäuser

    Được phát hành 2024
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  18. 18
    An overview and a roadmap for artificial intelligence in hematology and oncology

    An overview and a roadmap for artificial intelligence in hematology and oncology Bằng Wiebke Rösler, Michael Altenbuchinger, Bettina Baeßler, Tim Beißbarth, Gernot Beutel, Robert M. Bock, Nikolas von Bubnoff, Jan‐Niklas Eckardt, Sebastian Foersch, Chiara Maria Lavinia Loeffler, Jan Moritz Middeke, Martha-Lena Mueller, Thomas Oellerich, Benjamin Risse, André Scherag, Christoph Schliemann, Markus Scholz, Rainer Spang, Christian Thielscher, Ioannis Tsoukakis, Jakob Nikolas Kather

    Được phát hành 2023
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:
  19. 19
    Karyotype complexity and prognosis in acute myeloid leukemia

    Karyotype complexity and prognosis in acute myeloid leukemia Bằng Friedrich Stölzel, Brigitte Mohr, Michael Krämer, Uta Oelschlägel, Tilmann Bochtler, Wolfgang E. Berdel, Martin Kaufmann, Claudia D. Baldus, K. Schäfer-Eckart, Reingard Stuhlmann, H. Einsele, Stefan W. Krause, Hubert Serve, Matthias Hänel, Regina Herbst, Andreas Neubauer, Kristina Sohlbach, Jiří Mayer, Jan Moritz Middeke, Uwe Platzbecker, Markus Schaich, Andrea Krämer, Christoph Röllig, Johannes Schetelig, Martin Bornhäuser, Gerhard Ehninger

    Được phát hành 2016
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  20. 20
    <i><scp>TP</scp>53</i> mutation in patients with high‐risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation

    <i><scp>TP</scp>53</i> mutation in patients with high‐risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation Bằng Jan Moritz Middeke, Sylvia Herold, Elke Rücker‐Braun, Wolfgang E. Berdel, Matthias Stelljes, Martin Kaufmann, Kerstin Schäfer‐Eckart, Claudia D. Baldus, Reingard Stuhlmann, Anthony D. Ho, Hermann Einsele, Wolf Rösler, Hubert Serve, Mathias Hänel, Kristina Sohlbach, Christian Klesse, Brigitte Mohr, Falk Heidenreich, Friedrich Stölzel, Christoph Röllig, Uwe Platzbecker, Gerhard Ehninger, Martin Bornhäuser, Christian Thiede, Johannes Schetelig

    Được phát hành 2016
    lấy văn bản lấy văn bản
    Revisão
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: